Pfizer Post-Earnings: Shorts Creep Back as Analysts Lift Targets
Pfizer has just reported Q3 results, and the market's immediate reaction is quietly telling: the stock slipped 2.2% on Tuesday to $30.00, paring a week that still closes up 0.7%, while short interest has nudged back…